MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Major depressive disorder, single episode, unspecified (F32.9)

HealthDay 03 July at 01.58 PM

Perinatal Suicide Tied to Intimate Partner Problems, Depression, Substance Use

Perinatal suicide is often associated with intimate partner problems (IPPs) and behavioral health issues, according to a study published online June 27 in JAMA Network Open.Kara Zivin, Ph.D., from Michigan Medicine in Ann Arbor, and colleagues used data from the National Violent Death Reporting System (2003 through 2021) to

HealthDay 02 July at 04.02 PM

High Social Media Use Tied to Depression in Only Some Teens

High social media use is only tied to increased depression in teens who are already vulnerable, according to a study published online June 26 in the Journal of Adolescence.W. Justin Dyer, Ph.D., from Brigham Young University in Provo, Utah, and colleagues examined the varying ways early social media use was associated with the deve

HealthDay 01 July at 10.11 PM

Housing Insecurity Linked to Poorer Teen Health Outcomes

There is an association for housing insecurity starting in infancy and poorer adolescent outcomes, according to a study published online July 1 in Pediatrics.Kristyn A. Pierce, M.P.H., from the NYU Grossman School of Medicine in New York City, and colleagues created a composite measure of housing insecurity using five indicators for part

HealthDay 01 July at 10.10 PM

Small Differences in Weight Change With First-Line Antidepressants

For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted

HealthDay 28 June at 03.01 PM

Chronic Loneliness Linked to Increased Risk of Stroke

Chronic loneliness is associated with increased risk of stroke after adjustment for depressive symptoms and social isolation, according to a study published online June 24 in eClinicalMedicine.Yenee Soh, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a prospective cohort study using data fr

HealthDay 25 June at 09.41 PM

Health Status, Mental Health Worsened in U.S. Transgender Adults From 2014 to 2022

Health status, mental health, and health inequities worsened in the United States from 2014 to 2022 among transgender (TGD) adults, according to a research letter published online June 24 in JAMA Internal Medicine.Michael Liu, from Harvard Medical School in Boston, and colleagues evaluated recent trends in health status and mental

HealthDay 21 June at 10.57 PM

Social Anxiety Tied to Later Risk for Suicidal Ideation, Depression

Baseline social anxiety symptoms are associated with two-year suicidal ideation and depressive symptoms, according to a study published online June 10 in JCPP Advances.Kenny Chiu, Ph.D., from the University of East Anglia in the United Kingdom, and colleagues investigated the temporal associations between baseline social anxiety an

HealthDay 20 June at 08.53 PM

Prevalence of Mental Health Variables Higher for Adults Reporting Loneliness

The prevalence of mental health variables is higher among adults who report loneliness, with the highest prevalence of loneliness among bisexual and transgender adults, according to research published in the June 20 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Katherine V. Bruss, P

HealthDay 20 June at 03.57 PM

Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors

Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) have an increased burden of all chronic health conditions, disabilities, and limitations, according to a study published online June 20 in Cancer Epidemiology, Biomarkers & Prevention.Austin R. Waters, from the University of North Carolina a

Evalytics 08 April at 08.43 PM

FDA Clears Rejoyn: A New Era for App-Based Depression Treatment

The FDA approved Rejoyn, an app for treating major depressive disorder, as a complementary therapy to antidepressants. Developed by Otsuka America and Click Therapeutics, Rejoyn offers emotional training exercises and interactive messaging alongside traditional treatments.

HealthDay 19 January at 05.24 PM

Bidirectional Link ID'd for Autoimmune Disease, Perinatal Depression

There is a bidirectional association between autoimmune disease (AD) and perinatal depression (PND), according to a study published online Jan. 9 in Molecular Psychiatry.Emma Bränn, from the Karolinska Institutet in Stockholm, and colleagues examined the bidirectional association between PND and AD using nationwide Swedish population an

HealthDay 05 January at 04.59 AM

Half of Global Population May Have a Mental Disorder by Age 75 Years

By age 75 years, approximately half the global population can expect to develop a mental disorder, according to a study published online July 30 in The Lancet Psychiatry.John J. McGrath, Ph.D., from Queensland Centre for Mental Health Research in Brisbane, Australia, and colleagues used data from 156,331 adult participants in the World M

HealthDay 03 January at 03.52 PM

Sequential Bilateral Neurostimulation Aids Treatment-Resistant Depression

A novel sequential bilateral neurostimulation protocol has the potential to improve treatment-resistant major depressive disorder (TR-MDD), according to a letter published in the November issue of Brain Stimulation.Sabrina K. Segal, Ph.D., from the Family Care Center in Lone Tree, Colorado, and colleagues conducted a naturalistic

HealthDay 02 January at 04.39 PM

Depression, Anxiety Elevated for Spanish Speakers Receiving Radiation

Among women undergoing radiation therapy for breast cancer, Spanish speakers have an increased risk for depression and anxiety, according to a study published online Dec. 7 in the International Journal of Radiation Oncology, Biology and Physics.Corina Beiner, from the Boston University Chobanian & Avedisian School of Medicine, and c

HealthDay 29 December at 04.12 PM

Multiple Instruments Can Best Assess Transcranial Magnetic Stimulation Success

Symptom burden during repetitive transcranial magnetic stimulation (rTMS) treatment for major depressive disorder (MDD) may be most accurately assessed through use of multiple instruments, according to a study published in the December issue of Psychiatry Research.Michael K. Leuchter, M.D., from the University of California, Los An

Evalytics 22 December at 04.22 PM

Psychedelic psilocybin-assisted therapy found to reduce depressive symptoms in adults with cancer and depression

A study shows that psilocybin-assisted therapy can effectively reduce depressive symptoms, offering promise as a treatment for major depressive disorder.

HealthDay 20 December at 05.04 PM

Social Determinants of Health Needs More Likely for Patients With ED Encounters

Patients with emergency department encounters are more likely to screen positive for social determinants of health (SDOH) needs, according to a research letter published online Dec. 19 in JAMA Network Open.Stacie Vilendrer, M.D., M.S.P.H., from the Stanford University School of Medicine in California, and colleagues conducted a cross

HealthDay 19 December at 04.43 PM

Psilocybin Effective for Reducing Depression in Patients With Cancer

For patients with cancer and major depressive disorder, psilocybin is effective for reducing depression severity and is acceptable from the patient perspective, according to two studies published online Dec. 18 in Cancer.Manish Agrawal, M.D., from Sunstone Therapies in Rockville, Maryland, and colleagues examined the safety, feasibilit

HealthDay 08 December at 04.30 PM

Tardive Dyskinesia Impacts Patients and Caregivers

Tardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.Rakesh Jain, M.D., M.P.H., from the Texas Tech University School of Medicine-Permian Basin in Midland, and colleagues conducted an online survey to assess pati

HealthDay 05 December at 11.00 PM

Five Health Conditions Linked to Subsequent Diagnosis of MS

Five health conditions are associated with subsequent diagnosis of multiple sclerosis, but they overlap with two other autoimmune diseases, according to a study published online Dec. 5 in Neurology.Octave Guinebretiere, from Sorbonne Université in Paris, and colleagues examined the association between diseases and symptoms diagnosed in

HealthDay 04 December at 04.51 PM

Pupillary Light Reflex Can Predict Improvement With rTMS in Depression

For patients with major depressive disorder (MDD), pretreatment pupillary light reflex (PLR) could predict clinical improvement with repetitive transcranial magnetic stimulation (rTMS) treatment, and improvement in depression is better for those receiving intermittent theta burst stimulation (iTBS), according to one study published online Oct. 15 in the

HealthDay 01 December at 11.09 PM

Metabolic Biomarkers May Aid Mood Disorder Diagnosis

Metabolomic profiling may improve the differential diagnosis of mood disorders, according to a proof-of-concept study published online Oct. 25 in JAMA Psychiatry.Jakub Tomasik, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined metabolomic biomarker signatures from dried blood spots among patients

HealthDay 28 November at 04.49 PM

Light at Night Tied to Higher Risk for Mental Health Disorders

Avoiding light at night and seeking natural light during the day may be an effective way to improve mental health, according to a study published online Oct. 9 in Nature Mental Health.Angus C. Burns, Ph.D., from Monash University in Melbourne, Australia, and colleagues examined associations between daytime and nighttime light expo

HealthDay 22 November at 04.20 PM

Pharmacogenomic Testing to Guide Antidepressant Use Beneficial in Major Depression

For patients with major depressive disorder, pharmacogenomics testing to guide antidepressant use yields population health gains and reduces health system costs, according to a study published online Nov. 14 in CMAJ, the journal of the Canadian Medical Association.Shahzad Ghanbarian, Ph.D., from the University of British Col